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Even though the seroprevalence of H. pylori may be high in the normal population, a minority develops peptic ulcer. Colonization
of the gastric mucosa by more pathogenic vacA strains of H. pylori seems to be associated with enhanced gastric inflammation and
duodenal ulcer. H. pylori genotyping from positive CLOtests was developed to determine the vacA genotypes and cagA status in 40
duodenal ulcer patients and for routine use. The pathogenic s1b/ m1/ cagA genotype was the most frequently occurring strain (17/
42.5%); only two (5%) patients presented the s2/ m2 genotype, the less virulent strain. Multiple strains were also detected in 17
(42.5%) patients. Multiple strains of H. pylori colonizing the human stomach have been underestimated, because genotyping has
been performed from cultures of H. pylori. We concluded that genotyping of H. pylori from a positive CLOtest had the advantages
of reducing the number of biopsies taken during endoscopy, eliminating the step of culturing H. pylori, and assuring the presence of
H. pylori in the specimen being processed.
DESCRIPTORS: Helicobacter pylori. Genotype. Duodenal ulcer. CLOtest.
Helicobacter pylori (H. pylori) are
curved or spiral-shaped Gram-negative
bacteria1. The organisms are found
close to the mucosal surface, in inter-
cellular positions or caught up in the
surface mucus of the stomach2. When
cultured on solid medium, the bacte-
rium assumes a rod shape; spiral forms
may be few or absent. After prolonged
culture, coccoid forms predominate1.
The colonization of the gastric mucosa
by H. pylori has been associated with
chronic gastritis, peptic ulcer disease,
and gastric cancer3-5.
Although the seroprevalence of H.
pylori may be high in the normal popu-
lation, a minority develops peptic ul-
cer6. Racial differences in H. pylori
seroprevalence and peptic ulcer fre-
quency were observed in Singapore;
Indians had a higher prevalence of H.
pylori antibodies but a lower frequency
of peptic ulcer than the Chinese. This
finding suggested that other environ-
mental or genetic factors may be in-
volved in peptic ulcer disease7. Another
possible explanation is the fact that
some strains are more pathogenic than
others6.
There are two types of H. pylori:
one (toxin +) can, and the other (toxin
-) cannot secrete a vacuolating cyto-
toxin, which is a protein encoded by
the vacA (vacuolating cytotoxin) gene8.
Toxin + strains also produce a 128 kDa
protein encoded by the cagA gene (cy-
totoxin-associated gene)9. Patients har-
boring the toxin + strain would be
prone to present gastric or duodenal
ulceration and gastric cancer10-13.
Four different families of vacA sig-
nal sequences (s1a, s1b, s1c, and s2)
and two different families of middle-
region alleles (m1 and m2) were char-
acterized in different H. pylori isolates.
The s1c allele was observed exclu-
sively in isolates from East Asia14. All
possible combinations of these vacA
regions were identified, with the excep-
tion of s2/ m1. Type s1/ m1 strains pro-
duced a higher level of cytotoxin ac-
tivity in vitro than the type s1/ m2
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strains; none of s2/ m2 strains pro-
duced detectable cytotoxin activity8,10-
12
. However, even though m2 cytotoxin
was inactive in the in vitro HeLa cell
cytotoxicity assay, the m2 cytotoxin
was able to induce vacuolization in pri-
mary gastric cells15.
The purpose of our study was to
develop a quick technique for routine
use of H. pylori genotyping from the
CLOtest. H. pylori genotyping directly
from gastric biopsy specimens has pre-
viously been described16-19. However,
the advantages of using the CLOtest
for genotyping would be a reduction of
the number of biopsies taken during
the endoscopy and the assurance of the
presence of H. pylori in the specimen
being processed for genotyping.
PATIENTS AND METHODS
Patients
Forty patients with duodenal ulcer
and with positive CLOtests were se-
lected for the study. All patients were
positive for H. pylori, based on histo-
logical findings in gastric biopsies done
at the same time that the CLOtest was
performed. Twenty patients were male
and 20 were female, with a mean age
of 48+ 13 yr.
CLOtest
The antral mucosal biopsy speci-
men was inserted into a homemade
urease test tube20. The urease reagent
was prepared by dissolving the follow-
ing in distilled water to a final volume
of 100 mL: 0.010 g yeast extract,
0.0091 g KH2PO4, 0.0095 g Na2HPO4,
2 g urea, and 15 drops of phenol red
0.5%; the pH of the solution was ad-
justed to 6.9. The urease reagent was
sterilized by filtration, dispensed into
0.5 mL aliquots, and stored at –20ºC.
If the urease enzyme of H. pylori was
present in the gastric biopsy, the result-
ing breakdown of urea caused the pH
to rise and the color of the solution to
turn from yellow to bright magenta.
The urease test tube was examined af-
ter a 24 h period.
DNA extraction
After the CLOtest reading at 24
hours, the CLOtest tubes were stored
at 4ºC until DNA extraction. The whole
content of CLOtest including gastric
biopsy was collected by centrifugation
at 12 000 g for 25 min. The superna-
tant was discarded, and the pellet was
re-suspended in DNA extraction buffer
according to Sambrook et al.21, using
the phenol-chloroform method. The
DNA pellet was re-suspended in 30 µL
TE (10 mmol Tris-HCl pH 8.0, 1 mmol
EDTA pH 8.0).
Polymerase Chain Reaction
Genomic DNA (1.2- 6.0 µg) was
used as a template in a reaction volume
of 50 µL, containing 20 mmol Tris-HCl
(pH 8.4), 50 pmol of each primer, 200
µmol of each dNTP, and 2.5 U of Taq
DNA polymerase (Gibco BRL,
Gaithersburg, MD, USA). The Poly-
merase Chain Reaction (PCR) was per-
formed in a 2400 GeneAmp PCR sys-
tem (Perkin Elmer, Branchburg, NJ,
USA). Amplification was performed
under the following conditions for
vacA (m1, m2, s1a, s1b, s2)10 and
cagA9 (Table 1): initial denaturation at
94ºC for 5 min followed by 27 cycles
of denaturation at 94ºC for 30s, anneal-
ing at 53ºC for 30s and extension at
72ºC for 30s. The final extension at
72ºC was for 7 min. Gene Amp
lambda control reagents (Perkin Elmer,
Branchburg, NJ, USA); control tem-
plate lambda DNA and primers were
included as positive PCR reaction in-
ternal control. Negative PCR reaction
internal control was performed by ex-
cluding H. pylori genomic DNA in one
of the PCR reaction tubes. One set of
primers (P1 and P2)16 that amplifies a
26 kDa antigen gene present in all
strains of H. pylori was used for the
negative PCR reaction cases according
to the following conditions: initial de-
naturation at 94ºC for 5 min followed
by 40 cycles of denaturation at 93ºC for
1 min, annealing at 57ºC for 2 min and
extension at 70ºC for 2 min. The final
extension at 70ºC was for 10 min.
Analysis of PCR products
Five microliters of each PCR mix-
ture were separated by electrophoresis
on 2% agarose (GIBCO BRL,
Gaithersburg, MD, USA) gels in TAE21
(0.04 M Tris-acetate, 0.001M EDTA
pH 8.0) and 0.5 µg/mL ethidium bro-
mide. TAE was also used for electro-
phoresis buffer. PCR mixtures and 50
bp DNA ladder (GIBCO BRL,
Gaithersburg, MD, USA) were loaded
into slots in 6x loading buffer (0.25%
bromophenol blue, 0.25% xylene
cyanol FF, and 3% glycerol in water)21.
RESULTS
The PCR technique from the posi-
tive CLOtest tubes could be easily ap-
plied for the characterization of H. py-
lori strains. VacA and cagA genotypes
of H. pylori were analyzed in 40
duodenal ulcer patients that were diag-
nosed positive for H. pylori by means
of histology. Three patients were not
included in the study because no PCR
product could be obtained, even using
one set of primers (P1 and P2) that
amplifies a 26kDa antigen present in
all strains of H. pylori and 6 µg of ge-
nomic DNA. The DNA extracted from
the biopsies studied, except for the
ones that had multiple strains, gave
PCR products of expected sizes (Fig.
1).
Analysis of the vacA and cagA sta-
tus in these 40 patients (Table 2) re-
vealed that 17 (42.5%) patients had
s1b/ m1/ cagA, 17 (42.5%) patients
had multiple strains, 2 (5%) patients
had s1a/ m1/ cagA, 2 (5%) patients had
s1b/ m2/ cagA, and 2 (5%) patients
had s2/ m2.
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1) the reduction of the number of bi-
opsies taken during endoscopy; 2) the
assurance of the presence of H. pylori
in the specimen being processed, and
3) the avoidance of time-consuming
culturing of the strains.
The determination of the vacA
genotype was possible in more than
90% of the positive CLOtests, in agree-
ment with another report18, since only
3 patients were not included in this
study because no PCR product could
be obtained. A low density of H. py-
lori on the gastric mucosa could be re-
sponsible for a negative PCR, as the
sensitivity of the PCR detection of H.
pylori in gastric biopsies was approxi-
mately of 70-100 bacterial cells16,18.
One set of primers (P1 and P2)16 that
amplifies a 26 kDa antigen present in
all strains of H. pylori was also used
to make sure that the negative PCR re-
actions were due to a low density of H.
pylori, instead of the genotyping tech-
nique itself. Actually, typing of the
vacA gene was not possible in five
strains by other authors22, because of a
61-bp insertion in the signal region of
two strains, and for unknown reasons
in the others.
The s1b/ m1/ cagA genotype was
the most frequent strain (42.5%) ob-
served in these patients; a similar re-
sult has already been described in an-
other study of H. pylori strains from
Brazil23. A high prevalence of vacA s1b
alleles was also reported in South Af-
rica13 and Portugal24. However, vacA
Table 2 - vacA and cagA status of H.
pylori strains from CLOtests of 40
patients with duodenal ulcer.
Genotype status Patients (%)
s1b/ m1 / cagA 17 (42.5%)
s1a/ m1 / cagA 2 (5%)
s1b/ m2 / cagA 2 (5%)
s2/ m2 2 (5%)
Multiple strains 17 (42.5%)
Table 1 - Primers used for genotyping H. pylori vacA alleles 10 and cagA status 9.
Region Primer name Primer sequence PCR product size
m1 VA3-F 5’- GGTCAAAATGCGGTCATGG-3’ 290 bp
VA3-R 5’- CCATTGGTACCTGTAGAAAC-3’
m2 VA4-F 5’- GGAGCCCCAGGAAACATTG-3’ 352 bp
VA4-R 5’-CATAACTAGCGCCTTGCAC-3’
s1a SS1-F 5’- GTCAGCATCACACCGCAAC-3’ 190 bp
VA1-R 5’- CTGCTTGAATGCGCCAAAC-3’
s1b SS3-F 5’- AGCGCCATACCGCAAGAG-3’ 187 bp
VA1-R 5’- CTGCTTGAATGCGCCAAAC-3’
s2 SS2-F 5’- GCTAACACGCCAAATGATCC-3’ 199bp
VA1-R 5’- CTGCTTGAATGCGCCAAAC-3’
CagA CAG-1 5’- AGACAACTTGAGCGAGAAAG-3’ 320bp
CAG-2 5’- TATTGGGATTCTTGGAGGCG-3’
Ag P1 5’-TGGCGTGTCTATTGACAGCGAGC-3’  298bp
P2 5’- CCTGCTGGGCATACTTCACCATG-3’
Ag: DNA sequence of a species-specific protein antigen of 26kDa molecular weight that was
present in all strains of H. pylori16.
Figure 1 - PCR genotyping of vacA and cagA status from one case with the s2/ m2 strain and
another case with the s1b/ m1/ cagA strain. Primers described in Table 1 were used for PCR reaction.
DISCUSSION
In the present study, we described
the analysis of H. pylori strains by PCR
from positive homemade CLOtests in
40 duodenal ulcer patients. Compared
to using gastric biopsies, the possibil-
ity of using the CLOtest for PCR
would have the following advantages:
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s1a alleles were more prevalent in Ja-
pan22 and in Northern and Eastern Eu-
rope23.
H. pylori strains of vacA signal se-
quence type s1a are associated with
more gastric inflammation and duode-
nal ulceration than are the s1b type.
VacA s2 strains are associated with less
inflammation and lower ulcer preva-
lence6; in the present study, a low
prevalence was also observed, as only
two (5%) patients with duodenal ulcer
had vacA s2/ m2 strain.
Multiple strains were detected at
the same rate (42.5%) as the s1b/ m1/
cagA genotype; the clinical relevance
of multiple strains in gastric biopsies
should be evaluated, because the viru-
lence-associated genotypes of the
strains was correlated with the clinical
outcome of the gastrointestinal disease
in some studies10-13, but not in others5,
14, 22, 25
.
The detection of a high frequency
of multiple strains could be explained
by the fact that genotyping was per-
formed directly from gastric biopsies;
other authors12,16-19 also obtained more
than one strain when using the same
approach. In contrast, when the step of
H. pylori culturing preceded
genotyping, a single strain may have
been picked up; thus, the frequency of
multiple strains in the stomach might
have been underestimated. According
to Van Doorn et al23 and Figura et al26,
purification of H. pylori strains by cul-
turing from a single colony universally
results in the detection of a single vacA
genotype; however, when the strains
used are not purified from a single
colony, they may reflect the presence
of multiple strains in the host’s stom-
ach.
Another aspect that has to be con-
sidered in the disease outcome (duode-
nal or gastric ulcer, gastric cancer, and
gastric mucosa-associated lymphoid
tissue lymphoma) of positive H. pylori
patients is the individual host’s re-
sponse to the H. pylori infection. The
cellular and humoral immune re-
sponses that are mounted against H.
pylori are vigorous; polymorpho-
nuclear leukocytes and macrophages,
as well as T and B lymphocytes, infil-
trate the gastric mucosa, and have been
shown to modify gastric acid secre-
tion27. Different gastric acid responses
to H. pylori have been associated with
variations in the gastritis patterns that
seem to determine disease outcome28,29.
Thus, the immune response of the host
does not clear the infection and leaves
the host prone to complications result-
ing from chronic inflammation30-33.
In a mechanism known as antigenic
mimicry, highly conserved immuno-
genic molecules expressed by infec-
tious pathogens may act as a trigger for
the induction of humoral and cellular
immune responses that cross-react with
host cellular antigens. H. pylori seems
to be very effective in inducing anti-
genic mimicry; antibodies against H.
pylori have been found to cross-react
with both antral mucosal cells and gas-
trin-producing cells. Such autoantibod-
ies were detected both in human and
in experimental work in rodents34.
In conclusion, genotyping from a
homemade CLOtest was successfully
developed for routine use in our labo-
ratory. Even though more virulent
strains of H. pylori were found in
duodenal ulcer patients, the host im-
mune responses to H. pylori should be
further evaluated.
RESUMO RHCFAP/3018
MATTAR R e col. – A genotipagem do
H. pylori de testes CLO positivos
em pacientes com úlcera duodenal.
Rev. Hosp. Clín. Fac. Med.
S. Paulo 55(5):155-160, 2000.
Apesar da prevalência do H. pylori
na população normal ser alta, somente
uma minoria desenvolve úlcera péptica.
A colonização da mucosa gástrica por
cepas mais patogênicas de H. pylori
tem sido associada com maior inflama-
ção gástrica e úlcera duodenal. A
genotipagem do H. pylori de testes
CLO positivos foi estabelecida para se
determinar os genótipos vacA e cagA
em 40 pacientes com úlcera duodenal
e para uso na rotina. O genótipo
patogênico s1b/m1/cagA foi o mais
freqüente (17/ 42,5%); apenas dois
(5%) pacientes apresentaram o
genótipo s2/m2, o que é o menos vi-
rulento. Cepas múltiplas também fo-
ram detectadas em 17 (42,5%) pacien-
tes. Cepas múltiplas colonizando o es-
tômago têm sido subestimadas, pelo
fato das genotipagens serem geralmen-
te realizadas a partir de culturas de H.
pylori. Nós concluímos que a
genotipagem do H. pylori a partir de
testes CLO positivos tem as vantagens
de reduzir o número de biópsias duran-
te a endoscopia, eliminar a etapa de
cultura do H. pylori, e a certeza da pre-
sença do H. pylori na amostra que está
sendo processada para a genotipagem.
DESCRITORES: Helicobacter py-
lori. Genótipo. Úlcera duodenal. Tes-
tes CLO.
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